Please login to the form below

Not currently logged in
Email:
Password:

Intercytex

This page shows the latest Intercytex news and features for those working in and with pharma, biotech and healthcare.

UK regenerative medicine projects get £8.5m boost

UK regenerative medicine projects get £8.5m boost. Cell Medica, Intercytex and Lonza Biologics among the companies to benefit. ... An £8.5m package of grants will be shared by 14 projects in development by companies that include Cell Medica,

Latest news

  • Take off

    Turnover was zero. Intercytex uses the body's own repair mechanisms to slow down ageing. ... Intercytex has a skin replacement product for burns, and is aiming for this to replace skin grafts.

  • Merger mania hits

    The company uses human cells for its skin and hair replacement products - a market that Intercytex believes is worth some $6bn in sales. ... Intercytex currently has a venous leg ulcer treatment in phase III trials and expects to release further

  • Bright backdrop

    On the new listings AIM front, where a wave of biotech and healthcare companies are thought to be putting the final touches to their plans for a flotation, Intercytex, a

  • Up and up?

    Meanwhile, Intercytex, a firm is working on a treatment for baldness, hopes to raise around £15m through a floatation on AIM.

  • Weathering the storm

    Intercytex seeks backing for serious wound product. Intercytex, the speciality pharmaceutical and biotech firm, posted a pre-tax loss of £11.6m on sales up 34 per cent to £111, 000. ... The company's lead product is a treatment for serious wounds and

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics